25 mg/day oral Tirzepatide 15 mg/week Retatrutide 12 mg/week Liraglutide 3.0 mg/day Factor Peak trial weight loss Semaglutide -14.9% at 68 wks (STEP 1) Tirzepatide -22.5% at 72 wks (SURMOUNT-1) Retatrutide -28.7% at 68 wks (TRIUMPH-4) Liraglutide -8% at 56 wks (SCALE) Factor FDA status (June 2026) Semaglutide Approved (T2D, obesity, CVD, MASH, CKD, oral) Tirzepatide Approved (T2D, obesity) Retatrutide Investigational - Phase 3 Liraglutide Approved (Saxenda obesity, Victoza T2D) Factor CV outcomes data Semaglutide Yes - SELECT (20% MACE drop) Tirzepatide SURPASS-CVOT ongoing Retatrutide TRIUMPH-3 ongoing Liraglutide Yes - LEADER (13% MACE drop) These compounds are not interchangeable
Important Considerations: GLP-1s Are Not Recommended During Pregnancy While GLP-1 RAs like Tirzepatide show promise in improving fertility outcomes, they are not recommended for use during pregnancy or when trying to conceive
These barrels are antiparallel with each other
Nitrous oxide can cause psychological dependence Shuford first tried a small canister of laughing gas during the couple's first Christmas together, after they met at a cannabis dispensary in 2018, and she instantly liked it, too
Tirzepatide is a GLP-1/GIP medication
